A Phase 1, Open-Label Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects

Trial Profile

A Phase 1, Open-Label Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Sep 2013

At a glance

  • Drugs Valbenazine (Primary) ; Ketoconazole
  • Indications Drug-induced dyskinesia; Gilles de la Tourette's syndrome; Schizophrenia
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 05 Aug 2013 New trial record
    • 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top